Abstract
The prevalence of poor response to gonadotropin stimulation is approximately 9–24% in women undergoing in vitro fertilization. Interestingly, due to containing a variety of growth factors, platelet-rich plasma (PRP) can play an important role in tissue regeneration and healing. Thus, in this research, we aimed to investigate the intra-ovarian injection of PRP in women with poor ovarian response. To this goal, 23 poor responders constituted the study population, from among whom 19 women were enrolled. These patients underwent ovarian stimulation according to the Shanghai protocol. Immediately after the first follicular puncture, 2 mL of PRP was injected into each ovary. 1 day after the first puncture and PRP injection, the second stimulation was initiated. Then, oocyte retrieval was followed. About 2–3 months after the first cycle, the patients underwent another treatment with ovarian stimulation according to the Shanghai protocol and then, follicular puncture was performed. The mean numbers of oocytes before and after PRP injection were 0.64 and 2.1, respectively. Two patients experienced spontaneous conceptions. The third case achieved clinical pregnancy and delivered a healthy baby in June 2018. The results of this study appeared to be the first report on the effects of intra-ovarian PRP injection on the increase of ovarian responses, even on the spontaneous conceptions of women with poor ovarian response.
Similar content being viewed by others
References
Jirge PR (2016) Poor ovarian reserve. J Hum Reprod Sci 9:62
Giovanale V, Pulcinelli F, Ralli E, Primiero F, Caserta D (2015) Poor responders in IVF: an update in therapy. Gynecol Endocrinol 31(4):253–257
Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, Shoham Z (2014) Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reprod BioMed Online 29(6):684–691. https://doi.org/10.1016/j.rbmo.2014.08.009
Moffat R, Pirtea P, Gayet V, Wolf JP, Chapron C, de Ziegler D (2014) Dual ovarian stimulation is a new viable option for enhancing the oocyte yield when the time for assisted reproductive technnology is limited. Reprodu BioMed Online 29(6):659–661. https://doi.org/10.1016/j.rbmo.2014.08.010
Sighinolfi G, Sunkara SK, La Marca A (2018) New strategies of ovarian stimulation based on the concept of ovarian follicular waves: from conventional to random and double stimulation. Reprod Biomed Online 37:489–497
Murase T, Iwase A, Komatsu K, Bayasula, Nakamura T, Osuka S, Takikawa S, Goto M, Kotani T, Kikkawa F (2017) Follicle dynamics: visualization and analysis of follicle growth and maturation using murine ovarian tissue culture. J Assist Reprod Genet. https://doi.org/10.1007/s10815-017-1073-5
Siess W (1989) Molecular mechanisms of platelet activation. Physiol Rev 69(1):58–178
Das D, Arur S (2017) Conserved insulin signaling in the regulation of oocyte growth, development, and maturation. Mol Reprod Dev 84:444–459
Emori C, Sugiura K (2014) Role of oocyte-derived paracrine factors in follicular development. Anim Sci J 85(6):627–633
Marini MG, Perrini C, Esposti P, Corradetti B, Bizzaro D, Riccaboni P, Fantinato E, Urbani G, Gelati G, Cremonesi F (2016) Effects of platelet-rich plasma in a model of bovine endometrial inflammation in vitro. Reprod Biol Endocrinol 14(1):58
Xie X, Zhang C, Tuan RS (2014) Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther 16(1):204
Sekerci C, Tanidir Y, Sener T, Sener G, Cevik O, Yarat A, Alev-Tuzuner B, Cetinel S, Kervancioglu E, Sahan A (2017) Effects of platelet-rich plasma against experimental ischemia/reperfusion injury in rat testis. J Pediatr Urol 13(3):e311–317
Jang H-Y, Myoung SM, Choe JM, Kim T, Cheon Y-P, Kim YM, Park H (2017) Effects of autologous platelet-rich plasma on regeneration of damaged endometrium in female rats. Yonsei Med J 58(6):1195–1203
Molina A, Sanchez J, Sanchez W, Vielma V (2018) Platelet-rich plasma as an adjuvant in the endometrial preparation of patients with refractory endometrium. JBRA Assist Reprod. https://doi.org/10.5935/1518-0557.20180009
Farimani M, Bahmanzadeh M, Poorolajal J (2016) A new approach using autologous platelet-rich plasma (PRP) to treat infertility and to improve population replacement rate. J Res Health Sci 16(3):172–173
Farimani M, Poorolajal J, Rabiee S, Bahmanzadeh M (2017) Successful pregnancy and live birth after intrauterine administration of autologous platelet-rich plasma in a woman with recurrent implantation failure: a case report. Int J Reprod Biomed 15(12):803
Scarpellini F, Sbracia M (2012) G-CSF treatment improves IVF outcome in women with recurrent implantation failure in IVF. J Reprod Immunol 94(1):103
Fung M, Grossman B, Hillyer C, Westhoff C (2014) American assocation of blood banks. Technical manual, 18th edn. American Association of Blood Banks, Bethesda, pp 645–661
Bassiouny YA, Dakhly DMR, Bayoumi YA, Hashish NM (2016) Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? a randomized, controlled trial. Fertil Steril 105(3):697–702
Chang Y, Li J, Chen Y, Wei L, Yang X, Shi Y, Liang X (2015) Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med 8(1):1286–1290
Sleer LS, Taylor CC (2007) Cell-type localization of platelet-derived growth factors and receptors in the postnatal rat ovary and follicle. Biol Reprod 76(3):379–390
Abir R, Nitke S, Ben-Haroush A, Fisch B (2006) In vitro maturation of human primordial ovarian follicles. Clinical significance, progress in mammals, and methods for growth evaluation. Histol Histopathol 21:887–898
Yoon S-J, Kim K-H, Chung H-M, Choi D-H, Lee W-S, Cha K-Y, Lee K-A (2006) Gene expression profiling of early follicular development in primordial, primary, and secondary follicles. Fertil Steril 85(1):193–203
Pinkas H, Fisch B, Rozansky G, Felz C, Kessler-Icekson G, Krissi H, Nitke S, Ao A, Abir R (2008) Platelet-derived growth factors (PDGF-A and-B) and their receptors in human fetal and adult ovaries. Mol Hum Reprod 14(4):199–206
Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM (1996) Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383(6600):531
Vitt UA, Hsueh AJ (2002) Stage-dependent role of growth differentiation factor-9 in ovarian follicle development. Mol Cell Endocrinol 186(2):211–217
Vitt U, Hayashi M, Klein C, Hsueh A (2000) Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 62(2):370–377
Pantos K, Nitsos N, Kokkali G, Vaxevanoglou T, Markomichali C, Pantou A, Grammatis M, Lazaros L, Sfakianoudis K Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women after autologous platelet-rich plasma treatment. In: Abstracts, ESHRE 32nd Annual Meeting (2016) pp 3–6
Sills ES, Rickers NS, Li X, Palermo GD (2018) First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol 34:1–5
Sfakianoudis K, Simopoulou M, Nitsos N, Rapani A, Pantou A, Vaxevanoglou T, Kokkali G, Koutsilieris M, Pantos K (2018) A case series on platelet-rich plasma revolutionary management of poor responder patients. Gynecol Obstet Investig 84:1–8
Van Blerkom J, Antczak M, Schrader R (1997) The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod (Oxford England) 12(5):1047–1055
Li Q, Geng X, Zheng W, Tang J, Xu B, Shi Q (2012) Current understanding of ovarian aging. Sci Chin Life Sci 55(8):659–669. https://doi.org/10.1007/s11427-012-4352-5
Modlich U, Kaup F-J, Augustin HG (1996) Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Investig; J Tech Methods Pathol 74(4):771–780
Redmer DA, Reynolds LP (1996) Angiogenesis in the ovary. Rev Reprod 1(3):182–192
Huey S, Abuhamad A, Barroso G, Hsu M-I, Kolm P, Mayer J, Oehninger S (1999) Perifollicular blood flow Doppler indices, but not follicular pO2, pCO2, or pH, predict oocyte developmental competence in in vitro fertilization. Fertil Steril 72(4):707–712
Robinson RS, Woad KJ, Hammond AJ, Laird M, Hunter MG, Mann GE (2009) Angiogenesis and vascular function in the ovary. Reproduction 138(6):869–881
Wulff C, Dickson SE, Duncan WC, Fraser HM (2001) Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization. Hum Reprod 16(12):2515–2524
Kang B-J, Wang Y, Zhang L, Xiao Z, Li S-W (2016) bFGF and VEGF improve the quality of vitrified-thawed human ovarian tissues after xenotransplantation to SCID mice. J Assist Reprod Genet 33(2):281–289
Fraser HM, Lunn SF (2000) Angiogenesis and its control in the female reproductive system. Br Med Bull 56(3):787–797
Truman AM, Tilly JL, Woods DC (2017) Ovarian regeneration: the potential for stem cell contribution in the postnatal ovary to sustained endocrine function. Mol Cell Endocrinol 445:74–84
Edessy M, Hosni HN, Shady Y, Waf Y, Bakr S, Kamel M (2016) Autologous stem cells therapy, the first baby of idiopathic premature ovarian failure. Acta Med Int 3(1):19
Funding
The study was funded by vice-chancellor for Research and Technology, Hamadan University of Medical Sciences, Iran (Grant No. 960115299).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Farimani, M., Heshmati, S., Poorolajal, J. et al. A report on three live births in women with poor ovarian response following intra-ovarian injection of platelet-rich plasma (PRP). Mol Biol Rep 46, 1611–1616 (2019). https://doi.org/10.1007/s11033-019-04609-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-019-04609-w